The financing round was backed by Maven Capital Partners, YFM Equity Partners, Triple Point Ventures, and regional funds to support US growth.
"Drug discovery is so exciting right now, as there are just so many incredible companies working on remarkable new therapeutics. Equally, we are at a time where there is a stupendous amount of untapped evidence, like cause-and-effect, sat dark and subsequently unused by these same companies. Our mission at Biorelate is to capture this untapped data and help them make sense of it. With this improved understanding we are empowering these companies to make better decisions and speed up the drug discovery process."
YFM Equity Partners backed the latest round to fund international growth and software rollout.
"It’s been a pleasure to support Wooshii on its exciting journey over the past three years, during which time the company has gone from strength to strength. Our latest investment will enable Wooshi to expand its US operation and rollout its innovative video insight software, both of which have the potential to scale the business even more rapidly."
YFM Equity Partners provided the majority of the £3.4m capital injection alongside contributions from management and chairman Richard Law.
"Vypr is addressing the nascent market for real time insights and intelligence that businesses need to enable them to make the right and most profitable decisions about what new products and propositions to develop and when to launch them. It is building both a strong market position and brand and has recruited an enviable group of household name clients that now base their decisions on Vypr Insights."
The Series A round was backed by YFM Equity Partners and Maven Capital Partners to support international expansion and product development.
"The demand we’re seeing for our technology to solve a genuine problem, experienced by all businesses that deal with contracts, has been extraordinary. It’s clear that most businesses have a challenge when it comes to scaling contract processes and making the entire process much easier and faster. Bolstered by YFM’s support, we are in prime position to develop our game-changing approach to digital contracting even further."
YFM Equity Partners has led a £4.5m investment into the DevOps analytics platform to expand commercial reach and product leadership.
"Effective technology delivery is mission critical for most organisations, hence the explosion of interest in applying data science to optimise the end-to-end software delivery process. Plandek is the only UK company recognised as a leading global vendor in the space. Our intelligent analytics helps software delivery teams deliver value faster and more predictably as Plandek continues to lead the data science revolution in DevOps."
